SIGA vs TBRG

SIGA presents a stark contrast between a pristine balance sheet and a collapsing operational core, evidenced by a Piotroski F-Score of 4/9 (Stable). While the company maintains zero debt and an exceptional current ratio of 11.83, the YoY revenue decline of -95.30% and an operating margin of -250.38% indicate a severe crisis in business continuity. The current price of $4.76 trades at a premium to both the Graham Number ($4.47) and the Intrinsic Value ($2.24), suggesting the stock is overvalued relative to its fundamentals. Technical trends are fully bearish, and the earnings track record shows a consistent failure to meet analyst expectations.

TBRG exhibits a strong operational turnaround indicated by a Piotroski F-Score of 7/9, yet it faces a severe valuation disconnect. While the current price of $23.18 trades at a massive premium to the Graham Number ($8.94) and Intrinsic Value ($2.03), the Forward P/E of 7.92 and PEG of 0.28 suggest the market is pricing in an aggressive earnings explosion. The company's pivot to Revenue Cycle Management (RCM) is yielding significant EPS surprises, but thin profit margins and market saturation in the small-hospital segment remain critical headwinds.